Kymera Therapeutics Company
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Connections from
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
PharmTech
Technology:
Others
Founded Date:
2017
Headquarters:
Cambridge, Massachusetts, United States
Employee Number:
11-50